rs887829
|
|
Cholelithiasis
|
A |
0.810 |
GeneticVariation
|
GWASCAT |
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.
|
22558097 |
2012 |
rs10178992
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs10179091
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs10929301
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs10929302
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs11563251
|
|
Low density lipoprotein cholesterol measurement
|
T |
0.800 |
GeneticVariation
|
GWASCAT |
Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels.
|
28334899 |
2017 |
rs11563251
|
|
Serum total cholesterol measurement
|
T |
0.800 |
GeneticVariation
|
GWASCAT |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
rs11563251
|
|
Low density lipoprotein cholesterol measurement
|
T |
0.800 |
GeneticVariation
|
GWASCAT |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
rs11673726
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs11695484
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs11888459
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs11891311
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.
|
23371916 |
2013 |
rs12988520
|
|
Bilirubin measurement
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs17862875
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs17863787
|
|
Bilirubin measurement
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs17863787
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |
rs1875263
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |
rs2070959
|
|
Bilirubin measurement
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs28946889
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
rs3755319
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |
rs4148323
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.
|
23371916 |
2013 |
rs4148323
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
The protein coding variant rs4148323, which is monomorphic in European-derived populations, may be specifically associated with serum bilirubin levels in Asians (P = 2.56 x 10(-70)).
|
20639394 |
2010 |
rs4148324
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs4148325
|
|
Bilirubin measurement
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs4148325
|
|
Bilirubin measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |